AntidiabeticsINTRAVENOUSStandard
MYXREDLIN
INSULIN HUMAN
Standard Dose
100 UNITS/100ML (1 UNIT/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MYXREDLIN is listed in Drugs@FDA under application 208157 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN HUMAN Form and strength SOLUTION;INTRAVENOUS - 100 UNITS/100ML (1 UNIT/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-03-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview MYXREDLIN is listed in Drugs@FDA under application 208157 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN HUMAN Form and strength SOLUTION;INTRAVENOUS - 100 UNITS/100ML (1 UNIT/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-03-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.